COVINGTON, Ky. — CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately-held, full-service contract research organization, announced Wednesday it plans U.S. expansion on both East and West coasts.
The company is expanding their current office footprint in Raleigh, N.C., doubling the current space to accommodate immediate and future growth. CTI has also moved their West Coast office in San Francisco to a larger space that is more accessible to biopharma companies, the downtown area, and the airport.
“We’re excited to continue growing across the United States outside of our headquarters in Covington,” remarks Timothy J. Schroeder, founder and CEO. “The expanded office in Raleigh and the new office in San Francisco will allow us to continue to accommodate our ever expanding workforce and to tap into the rich populations in both cities for new talent.”
CTI, with an annual staff retention rate of 95%, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 120 pharmaceutical, biotechnology, and medical device clients. The company moved their global corporate headquarters to Northern Kentucky in 2017.